Product Information
DROXIDOPA 200 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $1.1305 per EA under NDC 67877070590. Its NADAC has been published 167 times since Feb 22, 2023.
Strength
200 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877070590
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA213911On Market Since
2/19/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 200 MG CAPSULE has been published 167 times since Feb 22, 2023, and over the history we have for it it has declined 46.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1305 per EA |
|---|---|
| All-time high | $2.3453 (Jul 10, 2024) |
| All-time low | $1.1305 (Jun 17, 2026) |
| 52-week high | $1.7346 |
| 52-week low | $1.1305 |
| Median price | $1.7543 |
| Average price | $1.8110 |
| Largest weekly change | -25.1% (Jul 17, 2024) |
| Weeks tracked | 167 |
| Tracking since | Feb 22, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DROXIDOPA 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 200 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $1.1305 per EA (NDC 67877070590), effective Jun 24, 2026.
How has the price of DROXIDOPA 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 200 MG CAPSULE has declined 46.9%. It has been tracked across 167 weekly CMS publications since Feb 22, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 200 MG CAPSULE?
Since Feb 22, 2023, the NADAC for DROXIDOPA 200 MG CAPSULE has ranged from a low of $1.1305 (Jun 17, 2026) to a high of $2.3453 (Jul 10, 2024), with a median of $1.7543 per EA.
Are there cheaper alternatives to DROXIDOPA 200 MG CAPSULE?
6 NADAC-published products share the same active ingredient, strength, and dosage form as DROXIDOPA 200 MG CAPSULE, but none are currently priced below it.
Who manufactures DROXIDOPA 200 MG CAPSULE?
DROXIDOPA 200 MG CAPSULE (NDC 67877070590) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification